EGFR and adenoma: A systematic review published by INCISE identified 49 gene mutations, single nucleotide polymorphisms, or haplotypes in 23 different genes/chromosomal regions (including KRAS, APC, EGFR, and COX1/2) that predicted metachronous adenoma or advanced adenoma development.